These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2984980)

  • 41. Echinacea purpurea for prevention of experimental rhinovirus colds.
    Sperber SJ; Shah LP; Gilbert RD; Ritchey TW; Monto AS
    Clin Infect Dis; 2004 May; 38(10):1367-71. PubMed ID: 15156472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ascorbic acid for the common cold. A prophylactic and therapeutic trial.
    Karlowski TR; Chalmers TC; Frenkel LD; Kapikian AZ; Lewis TL; Lynch JM
    JAMA; 1975 Mar; 231(10):1038-42. PubMed ID: 163386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-alpha 2.
    Phillpotts RJ; Scott GM; Higgins PG; Wallace J; Tyrrell DA; Gauci CL
    Antiviral Res; 1983 Aug; 3(2):121-36. PubMed ID: 6312877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sites of virus recovery and antigen detection in epithelial cells during experimental rhinovirus infection.
    Turner RB; Winther B; Hendley JO; Mygind N; Gwaltney JM
    Acta Otolaryngol Suppl; 1984; 413():9-14. PubMed ID: 6099954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased virus shedding with aspirin treatment of rhinovirus infection.
    Stanley ED; Jackson GG; Panusarn C; Rubenis M; Dirda V
    JAMA; 1975 Mar; 231(12):1248-51. PubMed ID: 163931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults.
    Sperber SJ; Levine PA; Innes DJ; Mills SE; Hayden FG
    J Infect Dis; 1988 Jul; 158(1):166-75. PubMed ID: 2839579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds.
    Turner RB
    Clin Infect Dis; 2001 Dec; 33(11):1865-70. PubMed ID: 11692298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rhinovirus colds.
    Phillpotts RJ; Tyrrell DA
    Br Med Bull; 1985 Oct; 41(4):386-90. PubMed ID: 2996687
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds.
    Sperber SJ; Sorrentino JV; Riker DK; Hayden FG
    Bull N Y Acad Med; 1989 Jan; 65(1):145-60. PubMed ID: 2557947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of illness from rhinovirus infection by a topical interferon inducer.
    Panusarn C; Stanley ED; Dirda V; Rubenis M; Jackson GG
    N Engl J Med; 1974 Jul; 291(2):57-61. PubMed ID: 4365144
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial.
    Eccles R; Winther B; Johnston SL; Robinson P; Trampisch M; Koelsch S
    Respir Res; 2015 Oct; 16():121. PubMed ID: 26438038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Small particle aerosols of enviroxime-containing liposomes.
    Gilbert BE; Six HR; Wilson SZ; Wyde PR; Knight V
    Antiviral Res; 1988 Sep; 9(6):355-65. PubMed ID: 3228281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiviral effect of 3, 4-dihydro-1-isoquinolineacetamide hydrochloride in experimental human rhinovirus infection.
    Togo Y; Schwartz AR; Hornick RB
    Antimicrob Agents Chemother; 1973 Dec; 4(6):612-6. PubMed ID: 4367686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ipratropium bromide treatment of experimental rhinovirus infection.
    Gaffey MJ; Hayden FG; Boyd JC; Gwaltney JM
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1644-7. PubMed ID: 2855297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial.
    Sperber SJ; Hendley JO; Hayden FG; Riker DK; Sorrentino JV; Gwaltney JM
    Ann Intern Med; 1992 Jul; 117(1):37-41. PubMed ID: 1317694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double-blind, placebo-controlled clinical trial of the effect of chlorpheniramine on the response of the nasal airway, middle ear and eustachian tube to provocative rhinovirus challenge.
    Doyle WJ; McBride TP; Skoner DP; Maddern BR; Gwaltney JM; Uhrin M
    Pediatr Infect Dis J; 1988 Mar; 7(3):229-38. PubMed ID: 3282216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds.
    Proud D; Gwaltney JM; Hendley JO; Dinarello CA; Gillis S; Schleimer RP
    J Infect Dis; 1994 May; 169(5):1007-13. PubMed ID: 8169385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The aetiology and epidemiology of common colds, and the possibilities of prevention.
    Reed SE
    Clin Otolaryngol Allied Sci; 1981 Dec; 6(6):379-87. PubMed ID: 6172222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Virucidal hand treatments for prevention of rhinovirus infection.
    Turner RB; Hendley JO
    J Antimicrob Chemother; 2005 Nov; 56(5):805-7. PubMed ID: 16159927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 'new' generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions.
    Al-Nakib W; Tyrrell DA
    Antiviral Res; 1987 Nov; 8(4):179-87. PubMed ID: 2833156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.